Abiopharma

TruBridge, Inc.: TruBridge Announces Extension of Cooperation Agreement with Pinetree Capital

BENKOWITZ MICHAEL 🟡 adjusted position in 14.6K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $494.27 ($10.6M) Transaction Date: Jan 05, 2026 | Filing ID: 000004

(99% Neutral) Biofrontera Inc. (BFRI) Files Form 8-K

(99% Neutral) ONCOTELIC THERAPEUTICS, INC. (OTLC) Announces Business Combination

BENKOWITZ MICHAEL 🟡 adjusted position in 7.9K shares (1 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $494.27 ($6.1M) Transaction Date: Jan 05, 2026 | Filing ID: 000003

Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth

(99% Neutral) MSP Recovery, Inc. (LIFWZ) Announces Business Combination

Rice Calvin 🟡 adjusted position in 6.2K shares (3 derivative) of Spok Holdings, Inc (SPOK) at $13.19 Transaction Date: Jan 05, 2026 | Filing ID: 006376

Pinto Shelly 🔴 sold 3.9K shares of ALX ONCOLOGY HOLDINGS INC (ALXO) at $1.11 Transaction Date: Jan 06, 2026 | Filing ID: 006374

Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth

📋 AUERBACH ALAN H (Officer) plans to sell 18K shares of PUMA BIOTECHNOLOGY, INC. (at $5.88 each, total $106K) Filed: Jan 07, 2026 | ID: 000194

Andrade Robert 🟡 adjusted position in 0 shares (1 derivative) of FENNEC PHARMACEUTICALS INC. (FENC) at $2.45 Transaction Date: Jan 07, 2026 | Filing ID: 000004

📋 LOUIS W SULLIVAN (Director) plans to sell 26K shares of EMERGENT BIOSOLUTIONS INC (at $13.99 each, total $360K) Filed: Jan 07, 2026 | ID: 000253

📋 CARL DAMBKOWSKI (Officer) plans to sell 35K shares of APOGEE THERAPEUTICS INC (at $78.25 each, total $2.8M) Filed: Jan 07, 2026 | ID: 000250

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results